Quest Diagnostics Inc

DGX: XNYS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
^lfLOCK|Dw&#tLOCK|g@xp?>?

Quest Continues to Enjoy a Narrow Moat Thanks to Its Status as Low-Cost Producer

Business Strategy and Outlook

Quest Diagnostics is a leading provider of independent diagnostic testing in the US thanks to its network of roughly 2,400 patient service centers across the country. Quest's scale-driven cost advantage allows the firm to benefit from several secular trends, including the proliferation of diagnostic tests and greater clinical reliance on personalized therapies. Additionally, Quest is enjoying a reprieve from Medicare-related pricing pressure as regulators tinker with the method for setting lab test reimbursement rates.

Sponsor Center